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Abstract
Acute coronary syndrome (ACS) is a life-threatening disease which remains a source of high morbidity and 
mortality despite advances in treatment. The relationship between serum uric acid (SUA) level and ischemic heart 
disease abides controversial and still has not been established as a cardiovascular risk factor. The cooperative 
interaction between those two factors is not fully understood. Prior epidemiological evidences of the causal 
relationship is still argumentative. There were various studies using the same methods yet the outcome were 
different. This study aims to conduct a meta-analysis to synthesize the results of recent studies in order to obtain 
data quantitatively and also accurately. Systematic study follows the guidelines for preferred reporting items for 
systematic reviews and meta-analysis (PRISMA), tracing studies published in vulnerable periods from January 
2010 to May 2020. The Cochrane Library, Ebsco, Medline/PubMed, ProQuest and Science Direct are sources of 
published studies. Meta-analysis was conducted to synthesize the associations between SUA level and severity of 
coronary artery stenosis, using random effect model to account for possible study heterogeneity. Heterogeneity 
was assessed using I2, and the meta-analysis was performed using Comprehensive Meta Analysis Version 3 (CMA3) 
software. Five studies (n=601 patients) identified a correlation between serum uric acid levels and Gensini scores 
(r=0.548; p<0.001) in ACS patients. Heterogeneity bias was found in the analysis, whereas publication bias was 
not found. Conclusion, severity of coronary artery stenosis in patients with ACS is positively correlated with 
serum uric acid levels. 
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Hubungan Kadar Asam Urat Serum dengan Keparahan Stenosis Arteri 
Koroner pada Pasien Sindrom Koroner Akut 
Abstrak
Sindrom koroner akut (SKA) adalah gangguan yang mengancam jiwa yang tetap menjadi sumber morbiditas dan 
mortalitas yang tinggi meskipun ada kemajuan dalam pengobatan. Hubungan antara asam urat serum dengan 
penyakit jantung iskemik masih kontroversial dan belum ditetapkan sebagai faktor risiko kardiovaskular. Interaksi 
kooperatif antara keduanya tidak sepenuhnya dipahami. Beberapa bukti epidemiologis hubungan kausal tersebut 
masih kontroversial. Sering sekali penelitian dengan kasus yang sama dan menggunakan metode yang sama tetapi 
hasilnya berbeda. Penelitian ini bertujuan melakukan meta analisis untuk mensintesis hasil-hasil penelitian yang 
berbeda tersebut agar diperoleh data baru yang bersifat kuantitatif dan lebih akurat. Telaah sistematis mengikuti 
pedoman preferred reporting items for systematic reviews and meta-analyses (PRISMA), dengan menelusuri studi 
yang dipublikasikan dalam rentan waktu dari Januari 2010 hingga Mei 2020. Cochrane Library, Ebsco, Medline/
PubMed, ProQuest, dan Science Direct adalah sumber dari studi yang dipublikasikan. Meta-analisis dilakukan untuk 
mensintesis korelasi antara kadar asam urat serum dan keparahan stenosis arteri koroner, menggunakan model 
efek acak untuk menjelaskan kemungkinan heterogenitas penelitian. Heterogenitas dinilai menggunakan I2, dan 
meta analisis menggunakan perangkat lunak Comprehensive Meta Analysis Version 3 (CMA3). Lima studi (n=601 
pasien) diidentifikasi didapatkan korelasi antara kadar asam urat serum dan skor Gensini (r=0,548; p<0,001) pada 
pasien SKA. Bias heterogenitas ditemukan dalam analisis, sedangkan bias publikasi tidak ditemukan. Simpulan, 
keparahan stenosis arteri koroner pada pasien dengan SKA berkorelasi positif dengan kadar asam urat serum.
Kata kunci: Asam urat, sindrom koroner akut, skor Gensini
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Introduction 
Cardiovascular disease (CVD) is a global primary 
cause of death which accounts for 4.1 million 
deaths in Europe alone. According to the WHO 
in 2019, 1.7 million of CVD-related deaths 
are caused by coronary artery disease (CAD). 
Acute Coronary Syndome (ACS) has become 
the primary cause of deaths and disabilities 
in Asia-Pacific, with more than 5% mortality 
in hospitalized patients.1the region still lacks 
consensus on the best approach to overcoming 
its specific challenges in reducing mortality 
from ACS. The Asia-Pacific Real world evIdenCe 
on Outcome and Treatment of ACS (APRICOT 
ACS covers a wide variety of clinical conditions, 
such as angina pectoris (UAP), non-ST elevation 
myocardial infarction (NSTEMI), dan  ST-elevation 
myocardial infarction (STEMI).2
Increased serum uric acid (SUA) level 
is a risk factor for cardiovascular disease 
(CVD). An increase in the SUA level is a common 
finding in patients with hypertension, insulin 
resistance, obesity, and CVD. However, it is 
still under debate whether such elevation is 
an independent predictor of cardiovascular 
risk or not. Nevertheless, the hypothesis that a 
reduction in the SUA level could prevent CVD has 
not been tested.3 A meta-analysis study reported 
that an increase in the SUA level significantly 
increases mortality and risk of major adverse 
cardiovascular events (MACE) and severe acute 
coronary artery diseases.4 Escalation in the SUA 
level correlates with cardiometabolic risks, which 
play a principal role in the pathophysiology of 
atherosclerotic formation. Increased uric acid 
level will increase the occurrence of endothelial 
dysfunction, oxidative stress, local inflammation, 
and insulin resistance, as well as inducing the 
proliferation of vascular smooth muscle cells 
that leads to vasoconstriction. This condition 
will trigger the development of atherosclerotic 
plaques, emphasizing its important role in the 
pathophysiology of cardiovascular disease.5
Acute coronary syndrome often reflects a 
degree of damages to the coronary arteries by 
atherosclerosis, plaque rupture, thrombosis, 
and inflammation. The SUA level in patients with 
ACS is higher than those with chronic coronary 
syndrome (CCS). As a result, many studies show 
a positive correlation between an increment in 
SUA levels and stenosis coronary artery score in 
patients with ACS.6,7number of diseased vessels, 
critical lesions and total occlusions on coronary 
angiogram. Results: Mean age of normouricemic 
group (n=59 The SUA level has a positive 
correlation with Gensini score and Syntax score 
in patients with CAD when compared to control. 
Furthermore, the SUA level associates with 
the amount of coronary artery atherosclerosis 
in patients with ACS.8 Several studies have 
analyzed the correlation between hyperuricemia 
and severity of coronary artery disease by 
comparing them with normouricemia in ACS 
patients. However, the hyperuricemia terms 
have various boundaries and interpretations, 
causing differences in the results. Until recently, 
no systematic review on the correlation between 
SUA level and coronary artery stenosis severity 
in patients with ACS has been conducted. Hence, 
this meta-analysis aimed to systematically 
analyze the correlation between SUA level and 
coronary artery stenosis severity in patients 
with ACS.
Methods
This study is registered with PROSPERO, 
CRD42020210948 and reported by following the 
recommendation and guideline of the Preferred 
Reporting Items of Systematic Reviews and Meta-
analyses (PRISMA). Two authors independently 
extracted data from published studies and meta-
analysis was conducted using the Comprehensive 
Meta Analisis version 3 (CMA 3) software. 
The authors conducted literature search 
in Cochrane Library, Ebsco, Medline/PubMed, 
ProQuest, and Science Direct. Where available, 
both controlled vocabulary terms and text words 
(MesH and keywords) were used in the subject 
component blocks. The search was conducted on 
studies published in English during the period of 
2010 to May 2020. This period was selected to 
provide a contemporary reflection of relationship 
between SUA and severity of coronary artery 
stenosis in ACS patients. Additional studies were 
identified by searching article reference lists and 
including grey literature from  the first 200 hits 
on Google Scholar after entering the index term 
combinations.
Sample was collected using PRISMA approach 
by applying the following  inclusion criteria: 
(i) literature observed a correlation between 
two variables or more; (ii)  used quantitative 
approach; (iii) included serum uric acid and 
coronary artery stenosis severity as research 
variables; (iv) subjects were patients with ACS; 
(v) and distinct diagnostic criteria for coronary 
artery stenosis severity measured with Gensini 
score was applied. Literature was excluded 
if it took the form of abstract, a piece from 
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Figure 1 PRISMA Flow Diagram on Study Inclusion and Exclusion and Their Rationale
Table 1 Description of Studies Included in Analysis
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book chapters, case reports, bulletin reviews, 
dissertations or thesis, and non-completed 
researche 
The reviewer independently performed title 
and abstract screening, data extraction, and 
risk of bias assessment. Then, an appraisal tool 
for Cross-Sectional Studies (AXIS) was used to 
assess the risk of bias. 
The analysis was conducted using CMA 
version 3 software. Statistical heterogeneity 
was assessed using the I2 statistic and the study 
would be considered to have a high degree of 
heterogeneity if the value was >75%. 
Results
The literature search, reviews, and reasons for 
study exclusion are described in Figure 1.
Critical analysis of five studies showed good 
quality reports and study designs. Those studies 
showed no bias in initial data collection; thus, 
67 full text were excluded
  -Irrelevant (n=52)
  -Chronic coronary syndrome 
    (n=14)
  -Chinese language (n=1)
duplication (n=268)







948 title were identified
78 abstract were reviewed 
72 full text were analysed
5 Full text meets the 
criteria for analysis (n=5)
Study design
Cross sectional study
870 article were excluded
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Table 2 Data Characteristics of Studies on Correlation between Uric Acid and Gensini Score
Study Sample size r 95% CI Z p
Weight (%)
Fixed Random
Duran et al., 2011 246 0,452 0,347─0,546 7,595 0,000 41.47 21.31
Gaubert et al., 2018 80 0,738 0,619─0,824 8,302 0,000 13.14 19.43
Ma et al., 2016 93 0,760 0,658─0,835 9,451 0,000 15.36 19.80
Pramanik et al., 2015 82 0,418 0,221─0,582 3,958 0,000 13.48 19.50
Qureshi et al., 2013 100 0,215 0,019─0,394 2,147 0,032 16.55 19.96
Fixed effects 601 0,519 0,458─0,576 13,931 <0,001 100.00 100.00
Random effects 601 0,548 0,328─0,711 4,397 <0,001 100.00 100.00
Figure 2 Forest Plot of Correlation between  
   Uric Acid and Gensini Score
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they were included in this systematic review 
and meta-analysis. Details on these studies are 
described in Table 1.
The systematic review of the five articles 
showed a positive correlation between uric 
acid level and severity of coronary artery 
stenosis (Gensini score) in ACS patients.6,9–12 
the relationship between SUA and severity 
of coronary atherosclerosis evaluated via 
endothelial dysfunction using peripheral arterial 
tone (PAT The secondary outcome demostrated 
that compared to normouricemia, hyperuricemia 
in ACS patients was associated with severity, 
wound area, and total occlusion number.6,10–12 
number of diseased vessels, critical lesions and 
total occlusions on coronary angiogram. Results: 
Mean age of normouricemic group (n=59 Results 
of the systematic review presented that the five 
studies were qualified to be analyzed using the 
the CMA3 program to evaluate the correlation 
between uric acid level and Gensini score. 
The total number of subjects included in these 
studies was 601 and the data characteristics of 
each study are presented in Table 2.
Variance analysis was performed to determine 
whether the studies were heterogeneous 
or homogenous. Studies were classified as 
heterogeneous if p-value <0.05 or I2 >75% in 
the heterogeneity test. After testing, studies 
included in this meta-analysis were found to be 
heterogenous, with I2=90.5% and p <0.001 (95% 
CI). Therefore, the model used to quantify pooled 
effect was the random effect model.
The Forest plot (Figure 2) showed the 
correlation between each study (black box) 
and its confidence interval (horizontal line). 
In addition, pooled correlations were depicted 
as diamond (red). A p-value of the forest plot 
was <0.05, resulting in the null hypothesis 
being rejected. Therefore, there was a positive 
correlation between uric acid level and severity 
of artery stenosis, with a correlation coefficient 
of 0.584, which could be categorized as moderate 
correlation. Also, the p-value in the significance 
test was 0.001, implying that the association 
between the two variables was significant. 
The quality assessment of the studies also 
considered the risk of bias. Report and design 
quality of all studies were classified as good 
according to the AXIS tool and all studies 
showed no initial bias. In terms of publication 
bias, because there were fewer than ten included 
studies, the utility of funnel plots to assess 
publication bias was limited as the power 
of the tests would be considered too low to 
distinguish chance from the actual asymmetry. 
The regression method (p=0.568) and rank 
correlation method (p=0.462) of this meta-
analysis provided a more objective means to 
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Table 3 Rank Correlation and Regression of Funnel pPot
Rank Correlation Method Regression Method
p-value Rank Correlation p-value Regression coeficient
0,462 0,735 0,568 0,639
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identify the presence of publication bias than a 
highly subjective visual inspection of the funnel 
plot (Table 3). There was no publication bias 
identified in this meta-analysis.
Discussion
This systematic review and meta-analysis is able 
to prove the correlation and comparability of 
uric acid and severity of coronary artery stenosis 
(Gensini score). Gensini score assessment gives 
weight to the closeness of the lesion in the left 
main coronary artery in addition to the stenosis 
degree, which leads to the maximum score. 
Therefore, the final score reflects the severity 
of coronary artery arteriosclerosis since it 
summarizes the cumulative effects of all lesions. 
The results of this systematic review and meta-
analysis are obtained from SKA patients with 
higher mean uric acid levels and in line with the 
findings of Fromonot et al. stating that the SUA 
levels are higher in ACS in comparison to chronic 
coronary syndrome (CCS).13 Elevated SUA levels 
are associated with side effects and mortality in 
patients with IMA, as well as with the severity 
and mortality of acute CAD. Also, increased 
levels of SUA are associated with an increased 
risk of subsequent clinical events and mortality 
in patients with CCS. Increase in the SUA level, 
even when it is only in a slight increase out of 
the normal range (hyperuricemia), has started 
to cause a significant increase in the short-term 
mortality of patients with STEMI and patients 
undergoing PCI.4 The study of Ma et al. reported 
an increase in SUA levels related to the clinical 
type of CAD.12 These results are in line with the 
research from Fromonot et al., reporting that 
patients with CAD have increased SUA levels 
compared to healthy people.13
This systematic evaluation and meta-analysis 
also described the correlation coefficients of 
SUA levels with moderate significant association 
to the severity of coronary artery stenosis. The 
magnitude of the determination coefficient (R 
square) is 0.300 or equal to 30%. This means that 
the SUA level variable simultaneously influences 
the severity of coronary artery stenosis by 
30%, while the remaining 70% is processed by 
other variables aside from other risk factors 
for atherosclerosis, both modified (such as 
dyslipidemia, smoking, Diabetes Mellitus/
insulin resistance, hypertension, chronic kidney 
disease (CKD), metabolic syndrome, systemic 
inflammation) and unmodified  (such as age, 
genetic and hereditary, and male gendermale).5 
Thus, increasing level of SUA is only considered 
as an adaptation response to try to prevent 
atherosclerosis due to the antioxidant properties 
of gout. Therefore, the SUA level can be 
considered a risk factor for atherosclerosis. This 
supports several studies that have revealed that 
increased levels of SUA are only considered an 
adaptation response as trial prevention against 
atherosclerosis due to the antioxidant properties 
of gout.4 
Uric acid (UA) is the end product of purine 
metabolism in humans and great apes. The UA 
acts as an antioxidant and accounts for 50% of 
the total antioxidant capacity of biological fluids 
in humans. When it presents in the cytoplasm 
of the cells or acidic/hydrophobic milieu in 
atherosclerotic plaques, UA converts into a pro-
oxidant agent and promotes oxidative stress. 
Through this mechanism, it participates in the 
pathophysiology of human disease, including 
CVD. Although the causality in the relationship 
between UA and CVD remains unproven, UA 
may be pathogenic and participates in the 
pathophysiology of CVD by serving as a bridging 
mechanism, mediating (enabling) or potentiating 
the deleterious effects of cardiovascular risk 
factors in vascular and myocardium tissue.5
The correlation between SUA and the 
severity of stenosis is made possible through 
the ACS pathomechanism process, which 
causes ischemia and acute myocardial necrosis 
due to severe coronary artery stenosis and 
even blockage. This ischemic state will induce 
anaerobic metabolism, which leads to low ATP 
production and the failure of ion exchange 
channels that disrupt enzymatic activity in 
the cytoplasm. Mitochondrial damage and 
electrolyte imbalance in the state of reperfusion 
increase oxidative stress through three 
primary systems, namely nicotinamide adenine 
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dinucleotide phosphate (NADPH) oxidase, nitric 
oxide synthase (NOS), and xanthine oxidase.14 
This increase in the xanthine oxidase system 
will further induce the production of reactive 
oxygen species (ROS) by oxidizing hypoxanthine 
to xanthine, then xanthine to uric acid, which in 
turn will cause a surge in purine metabolites in 
the circulation, leading to hyperuricemia.15 Thus, 
hyperuricemia has also been studied as a marker 
of poor prognosis and increased mortality in 
general, as well as other comorbidities found in 
CAD patients. The mechanism of hyperuricemia's 
role in the pathogenesis of atherosclerosis in 
ACS patients is made possible through the NF-
κB pathway that mediates endothelial disorders 
and vascular dysfunction, which are induced 
by hyperuricemia through reduction of nitric 
oxide (NO) and expression of pro-inflammatory 
cytokines. The link between activated NF-κB, NO 
reduction, maladaptive immune response, and 
vascular dysfunction enables the development 
of new therapeutic strategies to protect against 
cardiovascular disease.16 Further studies are 
required to reduce the effects of hyperuricemia 
with the severity of coronary artery stenosis. 
Thus, these results can support the notion of SUA 
level as a risk factor for atherosclerosis.
In conclusion, correlation between SUA and 
the severity of coronary artery stenosis in ACS is 
evident based on the metaanalysis in this study.
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